Primary record
(2R,3R,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2S,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4R,5R)-4-[(3R,4R,5R,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol
- 库存
- 3,253 克
- 纯度
- 99.3 %
- CAS
- 1405-10-3
化合物标识与属性
- CAS
- 1405-10-3
- PubChem CID
- 291576
- SMILES
- C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N.OS(=O)(=O)O
- Canonical SMILES
- NCC1OC(OC2C(CO)OC(OC3C(O)C(N)CC(N)C3OC3OC(CN)C(O)C(O)C3N)C2O)C(N)C(O)C1O.O=S(=O)(O)O
名称与同义词
- Bykomycin
- Neobiotic
- Otobiotic
- Framycetin sulfate
- Fradiomycin sulfate
- Mycaifradin sulfate
- Mycifradin
- Mycigient
- Myciguent
- Neofracin
- Biosol Veterinary
- Neomix
- Lidamycin creme
- Framycin sulfate
- Mycifradin-N
- Framycetin sulphate
- NEOMYCIN SULFATE
- Neomyein Sulfate
- Neo-Fradin
- Quintess-N
- Neomycin sulphate
- Neomycine sulfate
- Neomycins sulfate
- Neo-mantle creme
- New France F
- Neo-Rx
- Neomycin B sulfate
- Biosol (Veterinary)
- H2O4S.xUnspecified
- Neomix (Veterinary)
- Neomycin B trisulfate
- Neovet 325
- Caswell No. 595A
- Neomycin sulfate [USP]
- AC1Q6XEW
- Neomycin sulfate [USAN]
- H2-O4-S.x-Unspecified
- Neomycin, sulfate (salt)
- Neomicina, sulfato (sal),
- UNII-Y3720KZ4TQ
- USAF CB-19
- AC1L6G64
- Neomycin sulfate (internal use)
- C23H48N6O17S
- NSC156885
- BCP23598
- EINECS 215-773-1
- EINECS 223-969-3
- 1405-10-3
- AR-1F8578
- CID291576
- Fradiomycin sulfate;Neomycin sulphate
- MFCD00077833
- UNII-057Y626693
- C23H46N6O13.3H2O4S
- EPA Pesticide Chemical Code 006313
- Neomycin trisulfate salt hydrate powder
- NSC-156885
- 2-(chloromethyl)-4,6-dimethoxypyrimidine
- PD055536
- Neomycin sulfate (more than 75% b form)
- FT-0603559
- FT-0626547
- C23-H46-N6-O13.3H2-O4-S
- 25389-98-4
- 4,6-diamino-2-{[3-o-(2,6-diamino-2,6-dideoxyhexopyranosyl)pentofuranosyl]oxy}-3-hydroxycyclohexyl 2,6-diamino-2,6-dideoxyhexopyranoside sulfate(1:1)
- 4146-30-9
- 5-amino-2-(aminomethyl)-6-({4,6-diamino-2-[(4-{[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy}-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl)oxy]-3-hydroxycyclohexyl}oxy)oxane-3,4-diol; sulfuric acid
- 5-Amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol;sulfuric acid
- (2R,3R,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2S,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4R,5R)-4-[(3R,4R,5R,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol
- 25466-77-7
- 28002-70-2
- 5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol;sulfuric acid
- 5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol; sulfuric acid
- D-Streptamine, O-2,6-diamino-2,6-dideoxy-.beta.-L-idopyranosyl-(1?3)-O-.beta.-D-ribofuranosyl-(1?5)-O-[2,6-diamino-2,6-dideoxy-.alpha.-D-glucopyranosyl-(1?4)]-2-deoxy-, sulfate (1:3) (salt)